Status: current, Defined. Date: 30-Apr 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4805511000168116 | Bupivacaine 0.5% With Adrenaline 1 in 200 000 (Phebra) (bupivacaine hydrochloride monohydrate 100 mg / 20 mL + epinephrine 100 microgram / 20 mL) injection, 5 x 20 mL vials (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4805521000168111 | Bupivacaine 0.5% With Adrenaline 1 in 200 000 (Phebra) injection, 5 x 20 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Bupivacaine 0.5% With Adrenaline 1 in 200 000 (Phebra) injection, 5 x 20 mL vials | Is a | trade product pack | true | Inferred relationship | Some | ||
| Bupivacaine 0.5% With Adrenaline 1 in 200 000 (Phebra) injection, 5 x 20 mL vials | Is a | bupivacaine hydrochloride monohydrate 0.5% (100 mg/20 mL) + adrenaline (epinephrine) 1 in 200 000 (100 microgram/20 mL) injection, 5 x 20 mL vials | true | Inferred relationship | Some | ||
| Bupivacaine 0.5% With Adrenaline 1 in 200 000 (Phebra) injection, 5 x 20 mL vials | has TP | Bupivacaine 0.5% With Adrenaline 1 in 200 000 (Phebra) | true | Inferred relationship | Some | ||
| Bupivacaine 0.5% With Adrenaline 1 in 200 000 (Phebra) injection, 5 x 20 mL vials | has TPUU | Bupivacaine 0.5% With Adrenaline 1 in 200 000 (Phebra) injection, 20 mL vial | true | Inferred relationship | Some | 210768277 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Bupivacaine 0.5% With Adrenaline 1 in 200 000 (Phebra) injection, 5 x 20 mL vials | Is a | True | Bupivacaine 0.5% With Adrenaline 1 in 200 000 (Phebra) injection, 5 x 20 mL vials | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR